Skip to main content
. 2019 Feb 2;20(3):649. doi: 10.3390/ijms20030649

Figure 6.

Figure 6

IL-18 protection against cancer. (A) Robust proliferation of tumoricidal human γδT cells. IL-18 in combination with IL-2 activates and induces the proliferation of human CD56+CD11c+ precursor NK cells, which in turn robustly proliferate and activate γδT cells stimulated with γδT cell antigen produced by zoledronate (Zol)-treated monocytes (Mo). (B) Involvement of CLRs-mediated CARD9 inflammasome activation in the induction of colon cancer. Fungi in the intestinal microbial flora activate macrophages through C-type lectin receptors (CLRs), which promote Syk to activate caspase-1 via the CARD9 inflammasome. The resultant IL-18 is required for protection against colitis and colitis-associated cancer.